As the rate of advancements in the medtech sector continues to accelerate along with increasing demand, the importance and relevance of the world’s largest healthcare exhibition has never been more apparent.
MEDICA 2022 once again proved to be a vital shop window, innovation hub and networking event for the life sciences and healthcare sector, where companies in this dynamic, fast moving industry can meet, collaborate and establish relationships to help to meet the evolving needs of the market.
A prominent presence
The Medilink UK pavilion was prominently located in hall 16 which brought significant footfall to exhibitors. Jack Jakins, Senior Marketing Executive at Team Consulting expressed his satisfaction:
‘Medilink had a fantastic stand location within the UK pavilion. We had excellent footfall across each day and many useful conversations.’
2022 saw Medilink UK host their largest ever UK pavilion, accommodating some 60 companies wishing to expand their international presence, and supporting a further 40 companies attending trade missions with the Department for International Trade (DIT) from the North of England and Midlands regions. Their presence has grown year on year over the last two decades, becoming the Lead UK Partner of the Messe Düsseldorf.
Medilink’s pavilion included a broad range of medtech companies focused on entering new international markets, finding distributors and establishing new partnerships. Exhibitors included digital health companies, manufacturers of implants and prostheses; producers of medical instruments and consumables; suppliers of diagnostic, treatment and monitoring systems; and legal, financial, insurance and consulting services.
Before the 2022 show had closed, a record number of repeat bookings were being taken for the 2023 event, from both exhibitors new to the show that year, and those who regularly include MEDICA as a key element of their marketing strategy.
Lee Kirk, Head of Sales at LEEC Limited explained their reasons for exhibiting:
‘We exhibited at MEDICA a few years ago to launch new products in our range – the success of which helped us to expand as a business. We exhibited again in 2022 to meet new and existing contacts face-to-face following the COVID-19 pandemic, to obtain more global distribution partners. We met with people from as far as the Middle East and Indonesia and will definitely return to exhibit again.’
Medilink UK’s exhibition package includes access to funding for eligible businesses, support throughout the event, including briefings, meetings with DIT advisors, assistance with travel, shipping and accommodation and networking opportunities. It also includes specialist in-market PR support. For many companies this is a vital aspect of their participation. Peter Carroll, Director at Medezine Ltd explains why they choose to exhibit with Medilink UK:
‘We have worked with Medilink for 15 years on a number of occasions; their exhibition assistance is excellent, with everything from accommodation support to their links with the Department for International Trade for additional opportunities for UK exporters.’
In addition to the operational support for exhibitors on the UK pavilion, Medilink’s innovation and commercialisation specialists were on hand to offer market insight and guidance to help increase the probability of commercial success and profitability. Advisors are also available to provide information and help with understanding international healthcare settings including market access and opportunities, market dynamics, assessment criteria, reimbursement policies and regulatory landscapes.